Cesca Therapeutics Inc. (KOOL) Cut to “Sell” at ValuEngine
ValuEngine cut shares of Cesca Therapeutics Inc. (NASDAQ:KOOL) from a hold rating to a sell rating in a research note published on Wednesday morning.
Cesca Therapeutics (NASDAQ KOOL) traded down $0.10 during trading hours on Wednesday, hitting $3.43. The stock had a trading volume of 221,003 shares, compared to its average volume of 94,417. Cesca Therapeutics has a twelve month low of $2.41 and a twelve month high of $6.44. The company has a quick ratio of 1.67, a current ratio of 2.47 and a debt-to-equity ratio of 0.11.
Cesca Therapeutics Company Profile
Cesca Therapeutics Inc is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Cesca Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cesca Therapeutics Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.